Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 78


Synthetic Cannabinoids: Pharmacology, Behavioral Effects, and Abuse Potential.

Tai S, Fantegrossi WE.

Curr Addict Rep. 2014 Jun 1;1(2):129-136.


An endocannabinoid system is present in the mouse olfactory epithelium but does not modulate olfaction.

Hutch CR, Hillard CJ, Jia C, Hegg CC.

Neuroscience. 2015 Aug 6;300:539-53. doi: 10.1016/j.neuroscience.2015.05.056. Epub 2015 May 30.


Promising cannabinoid-based therapies for Parkinson's disease: motor symptoms to neuroprotection.

More SV, Choi DK.

Mol Neurodegener. 2015 Apr 8;10:17. doi: 10.1186/s13024-015-0012-0. Review.


Using the endocannabinoid system as a neuroprotective strategy in perinatal hypoxic-ischemic brain injury.

Lara-Celador I, Goñi-de-Cerio F, Alvarez A, Hilario E.

Neural Regen Res. 2013 Mar 15;8(8):731-44. doi: 10.3969/j.issn.1673-5374.2013.08.008.


Cannabinoid Regulation of Brain Reward Processing with an Emphasis on the Role of CB1 Receptors: A Step Back into the Future.

Panagis G, Mackey B, Vlachou S.

Front Psychiatry. 2014 Jul 31;5:92. doi: 10.3389/fpsyt.2014.00092. eCollection 2014. Review.


The novel endocannabinoid receptor GPR18 is expressed in the rostral ventrolateral medulla and exerts tonic restraining influence on blood pressure.

Penumarti A, Abdel-Rahman AA.

J Pharmacol Exp Ther. 2014 Apr;349(1):29-38. doi: 10.1124/jpet.113.209213. Epub 2014 Jan 15.


Δ(9)-THC and N-arachidonoyl glycine regulate BV-2 microglial morphology and cytokine release plasticity: implications for signaling at GPR18.

McHugh D, Roskowski D, Xie S, Bradshaw HB.

Front Pharmacol. 2014 Jan 2;4:162. doi: 10.3389/fphar.2013.00162. eCollection 2014.


The endocannabinoid system and sex steroid hormone-dependent cancers.

Ayakannu T, Taylor AH, Marczylo TH, Willets JM, Konje JC.

Int J Endocrinol. 2013;2013:259676. doi: 10.1155/2013/259676. Epub 2013 Nov 27. Review.


The promise and dilemma of cannabinoid therapy: lessons from animal studies of bone disease.

Idris AI.

Bonekey Rep. 2012 Nov 21;1:224. doi: 10.1038/bonekey.2012.224. Review.


Rod photoreceptors express GPR55 in the adult vervet monkey retina.

Bouskila J, Javadi P, Casanova C, Ptito M, Bouchard JF.

PLoS One. 2013 Nov 14;8(11):e81080. doi: 10.1371/journal.pone.0081080. eCollection 2013.


The Endocannabinoid System in the Postimplantation Period: A Role during Decidualization and Placentation.

Fonseca BM, Correia-da-Silva G, Almada M, Costa MA, Teixeira NA.

Int J Endocrinol. 2013;2013:510540. doi: 10.1155/2013/510540. Epub 2013 Oct 21. Review.


CB1 cannabinoid receptors couple to focal adhesion kinase to control insulin release.

Malenczyk K, Jazurek M, Keimpema E, Silvestri C, Janikiewicz J, Mackie K, Di Marzo V, Redowicz MJ, Harkany T, Dobrzyn A.

J Biol Chem. 2013 Nov 8;288(45):32685-99. doi: 10.1074/jbc.M113.478354. Epub 2013 Oct 2.


Modulation of the endocannabinoid system: vulnerability factor and new treatment target for stimulant addiction.

Olière S, Joliette-Riopel A, Potvin S, Jutras-Aswad D.

Front Psychiatry. 2013 Sep 23;4:109. doi: 10.3389/fpsyt.2013.00109. Review.


N-Arachidonoyl glycine suppresses Na⁺/Ca²⁺ exchanger-mediated Ca²⁺ entry into endothelial cells and activates BK(Ca) channels independently of GPCRs.

Bondarenko AI, Drachuk K, Panasiuk O, Sagach V, Deak AT, Malli R, Graier WF.

Br J Pharmacol. 2013 Jun;169(4):933-48. doi: 10.1111/bph.12180.


Cannabinoid modulation of neuroinflammatory disorders.

Saito VM, Rezende RM, Teixeira AL.

Curr Neuropharmacol. 2012 Jun;10(2):159-66. doi: 10.2174/157015912800604515.


Role of cannabinoids in the regulation of bone remodeling.

Idris AI, Ralston SH.

Front Endocrinol (Lausanne). 2012 Nov 16;3:136. doi: 10.3389/fendo.2012.00136. eCollection 2012.


siRNA knockdown of GPR18 receptors in BV-2 microglia attenuates N-arachidonoyl glycine-induced cell migration.

McHugh D, Wager-Miller J, Page J, Bradshaw HB.

J Mol Signal. 2012 Jul 26;7(1):10. doi: 10.1186/1750-2187-7-10.


Evidence for the putative cannabinoid receptor (GPR55)-mediated inhibitory effects on intestinal contractility in mice.

Ross GR, Lichtman A, Dewey WL, Akbarali HI.

Pharmacology. 2012;90(1-2):55-65. doi: 10.1159/000339076. Epub 2012 Jun 28.


GPR18 in microglia: implications for the CNS and endocannabinoid system signalling.

McHugh D.

Br J Pharmacol. 2012 Dec;167(8):1575-82. doi: 10.1111/j.1476-5381.2012.02019.x. Review.


Cannabinoid 2 (CB2) receptor involvement in the down-regulation but not up-regulation of serum IgE levels in immunized mice.

Newton CA, Klein TW.

J Neuroimmune Pharmacol. 2012 Sep;7(3):591-8. doi: 10.1007/s11481-012-9361-4. Epub 2012 May 4.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk